BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21795584)

  • 1. Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF-κB-regulated gene expression and sensitization of tumor cells to chemotherapeutic agents.
    Gupta SC; Kannappan R; Kim J; Rahman GM; Francis SK; Raveendran R; Nair MS; Das J; Aggarwal BB
    Mol Pharmacol; 2011 Nov; 80(5):769-81. PubMed ID: 21795584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.
    Anand P; Kunnumakkara AB; Harikumar KB; Ahn KS; Badmaev V; Aggarwal BB
    Cancer Res; 2008 Nov; 68(21):8861-70. PubMed ID: 18974130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells.
    Yadav VR; Prasad S; Gupta SC; Sung B; Phatak SS; Zhang S; Aggarwal BB
    J Biol Chem; 2012 Jan; 287(1):245-256. PubMed ID: 22065587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
    Takada Y; Singh S; Aggarwal BB
    J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morin (3,5,7,2',4'-Pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis.
    Manna SK; Aggarwal RS; Sethi G; Aggarwal BB; Ramesh GT
    Clin Cancer Res; 2007 Apr; 13(7):2290-7. PubMed ID: 17404114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
    Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
    Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.
    Takada Y; Kobayashi Y; Aggarwal BB
    J Biol Chem; 2005 Apr; 280(17):17203-12. PubMed ID: 15710601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents.
    Sandur SK; Ichikawa H; Sethi G; Ahn KS; Aggarwal BB
    J Biol Chem; 2006 Jun; 281(25):17023-17033. PubMed ID: 16624823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel blocker of I kappa B alpha kinase that enhances cellular apoptosis and inhibits cellular invasion through suppression of NF-kappa B-regulated gene products.
    Ichikawa H; Takada Y; Murakami A; Aggarwal BB
    J Immunol; 2005 Jun; 174(11):7383-92. PubMed ID: 15905586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer activities of Bharangin against breast cancer: Evidence for the role of NF-κB and lncRNAs.
    Awasthee N; Rai V; Verma SS; Sajin Francis K; Nair MS; Gupta SC
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2738-2749. PubMed ID: 30251663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
    Ahn KS; Sethi G; Aggarwal BB
    Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis.
    Sethi G; Ahn KS; Sung B; Aggarwal BB
    Mol Cancer Ther; 2008 Jun; 7(6):1604-14. PubMed ID: 18566231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation.
    Takada Y; Gillenwater A; Ichikawa H; Aggarwal BB
    J Biol Chem; 2006 Mar; 281(9):5612-22. PubMed ID: 16377638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis.
    Kunnumakkara AB; Ichikawa H; Anand P; Mohankumar CJ; Hema PS; Nair MS; Aggarwal BB
    Mol Cancer Ther; 2008 Oct; 7(10):3306-17. PubMed ID: 18852134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
    Sung B; Pandey MK; Aggarwal BB
    Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
    Takada Y; Ichikawa H; Badmaev V; Aggarwal BB
    J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression.
    Ichikawa H; Nair MS; Takada Y; Sheeja DB; Kumar MA; Oommen OV; Aggarwal BB
    Clin Cancer Res; 2006 Oct; 12(19):5910-8. PubMed ID: 17021000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.